{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:16Z","timestamp":1792099696400,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12072-020-10085-3","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:02:55Z","timestamp":1599498175000},"page":"869-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-1631","authenticated-orcid":false,"given":"Adil","family":"Baskiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6864-7711","authenticated-orcid":false,"given":"Sami","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-6115","authenticated-orcid":false,"given":"Tevfik Tolga","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-6772","authenticated-orcid":false,"given":"Cemalettin","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-7806","authenticated-orcid":false,"given":"Serdar","family":"Karakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-490X","authenticated-orcid":false,"given":"Volkan","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5419-7158","authenticated-orcid":false,"given":"Cihan","family":"Yurdaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-0297","authenticated-orcid":false,"given":"Sezai","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"issue":"3","key":"10085_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jceh.2013.08.004","volume":"3","author":"A Shukla","year":"2013","unstructured":"Shukla A, Vadeyar H, Rela M, Shah S. Liver transplantation: east versus west. J Clin Exp Hepatol 2013;3(3):243\u2013253. https:\/\/doi.org\/10.1016\/j.jceh.2013.08.004","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10085_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.virol.2005.09.033","volume":"344","author":"JM Taylor","year":"2006","unstructured":"Taylor JM. Hepatitis delta virus. Virology 2006;344(1):71\u201376. https:\/\/doi.org\/10.1016\/j.virol.2005.09.033","journal-title":"Virology"},{"issue":"4","key":"10085_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1478-3231.2008.01673.x","volume":"28","author":"H Degertekin","year":"2008","unstructured":"Degertekin H, Yalc\u03b9n K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008;28(4):494\u2013498. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01673.x","journal-title":"Liver Int"},{"issue":"9","key":"10085_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1478-3231.2012.02831.x","volume":"32","author":"B Heidrich","year":"2012","unstructured":"Heidrich B, Serrano BC, Idilman R, Kabacam G, Bremer B, Raupach R, Onder FO, Deterding K. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome. Liver Int 2012;32(9):1415\u20131425. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02831.x","journal-title":"Liver Int"},{"key":"10085_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jare.2019.03.009","volume":"17","author":"N Mentha","year":"2019","unstructured":"Mentha N, Cl\u00e9ment S, Negro F, Alfaiate D. A review on hepatitis D: from virology to new therapies. J Adv Res 2019;17:3\u201315. https:\/\/doi.org\/10.1016\/j.jare.2019.03.009","journal-title":"J Adv Res"},{"issue":"3","key":"10085_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0032-1323629","volume":"32","author":"C Yurdaydin","year":"2012","unstructured":"Yurdaydin C. Treatment of chronic delta hepatitis. Semin Liver Dis 2012;32(3):237\u2013244. https:\/\/doi.org\/10.1055\/s-0032-1323629","journal-title":"Semin Liver Dis"},{"key":"10085_CR7","doi-asserted-by":"publisher","first-page":"a021543","DOI":"10.1101\/cshperspect.a021543","volume":"5","author":"C Yurdaydin","year":"2015","unstructured":"Yurdaydin C, Idilman R. Therapy of delta hepatitis. Cold Spring Harb Perspect Med 2015;5:a021543. https:\/\/doi.org\/10.1101\/cshperspect.a021543","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10085_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/23744235.2016.1271998","volume":"49","author":"IH Bahcecioglu","year":"2017","unstructured":"Bahcecioglu IH, Sahin A. Treatment of delta hepatitis: today and in the future\u2014a review. Infect Dis (Lond) 2017;49(4):241\u2013250. https:\/\/doi.org\/10.1080\/23744235.2016.1271998","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"10085_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2006.10.038","volume":"132","author":"SH Choi","year":"2007","unstructured":"Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology 2007;132(1):343\u2013357. https:\/\/doi.org\/10.1053\/j.gastro.2006.10.038","journal-title":"Gastroenterology"},{"issue":"2","key":"10085_CR10","doi-asserted-by":"publisher","first-page":"a021444","DOI":"10.1101\/cshperspect.a021444","volume":"5","author":"MA Buendia","year":"2015","unstructured":"Buendia MA, Neuveut C. Hepatocellular carcinoma. Cold Spring Harb Perspect Med 2015;5(2):a021444. https:\/\/doi.org\/10.1101\/cshperspect.a021444","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10085_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12920-019-0580-x","volume":"12","author":"S Sun","year":"2019","unstructured":"Sun S, Li Y, Han S, Jia H, Li X, Li X. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma. BMC Med Genom 2019;12(1):147. https:\/\/doi.org\/10.1186\/s12920-019-0580-x","journal-title":"BMC Med Genom"},{"key":"10085_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12879-016-1992-2","volume":"16","author":"MA Amougou","year":"2016","unstructured":"Amougou MA, Noah DN, Moundipa PF, Pineau P, Njouom R. A prominent role of Hepatitis D virus in liver cancers documented in Central Africa. BMC Infect Dis 2016;16:647. https:\/\/doi.org\/10.1186\/s12879-016-1992-2","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10085_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1365-2893.2010.01353.x","volume":"17","author":"C Yurdaydin","year":"2010","unstructured":"Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010;17(11):749\u2013756. https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01353.x","journal-title":"J Viral Hepat"},{"issue":"2","key":"10085_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jmv.21078","volume":"80","author":"TJS Cross","year":"2008","unstructured":"Cross TJS, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, Vergani D, Harrison PM. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008;80(2):277\u2013282. https:\/\/doi.org\/10.1002\/jmv.21078","journal-title":"J Med Virol"},{"issue":"3","key":"10085_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 2000;46(3):420\u2013426. https:\/\/doi.org\/10.1136\/gut.46.3.420","journal-title":"Gut"},{"issue":"3","key":"10085_CR16","doi-asserted-by":"publisher","first-page":"e92062","DOI":"10.1371\/journal.pone.0092062","volume":"9","author":"R Romeo","year":"2014","unstructured":"Romeo R, Foglieni B, Casazza G, Spreafico M, Colombo M, Prati D. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta. PLoS One 2014;9(3):e92062. https:\/\/doi.org\/10.1371\/journal.pone.0092062","journal-title":"PLoS One"},{"issue":"3","key":"10085_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000;46(3):420\u2013426. https:\/\/doi.org\/10.1136\/gut.46.3.420","journal-title":"Gut"},{"key":"10085_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693\u2013699. https:\/\/doi.org\/10.1056\/NEJM199603143341104","journal-title":"N Engl J Med"},{"key":"10085_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-020-00424-w","author":"V Ince","year":"2020","unstructured":"Ince V, Akbulut S, Otan E, Ersan V, Karakas S, Sahin TT, Carr BI, Baskiran A, Samdanci E, Bag HG, Koc C, Usta S, Ozdemir F, Barut B, Gonultas F, Sarici B, Kutluturk K, Dogan MS, Ozgor D, Dikilitas M, Harputluoglu M, Aladag M, Kutlu R, Varol I, Dirican A, Aydin C, Isik B, Ara C, Kayaalp C, Emre S, Yilmaz S. Liver transplantation for hepatocellular carcinoma: Malatya experience and proposals for expanded criteria. J Gastrointest Cancer 2020. https:\/\/doi.org\/10.1007\/s12029-020-00424-w","journal-title":"J Gastrointest Cancer"},{"issue":"11","key":"10085_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2165\/00003088-200645110-00005","volume":"45","author":"BP Kearney","year":"2006","unstructured":"Kearney BP, Yale K, Shah J, Zhong L, Flaherty JF. Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment. Clin Pharmacokinet 2006;45(11):1115\u20131124. https:\/\/doi.org\/10.2165\/00003088-200645110-00005","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10085_CR21","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.transproceed.2019.01.163","volume":"51","author":"A Serin","year":"2019","unstructured":"Serin A, Tokat Y. Recurrence of hepatitis D virus in liver transplant recipients with hepatitis B and D virus-related chronic liver disease. Transplant Proc 2019;51(7):2457\u20132460. https:\/\/doi.org\/10.1016\/j.transproceed.2019.01.163","journal-title":"Transplant Proc"},{"key":"10085_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/s0168-8278(02)00162-9","volume":"37","author":"C Yurdaydin","year":"2002","unstructured":"Yurdaydin C, Bozkaya H, Gurel S, Tillmann HL, Aslan N, Okcu-Heper A, Erden E, Yal\u00e7in K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Famciclovir treatment of chronic delta hepatitis. J Hepatol 2002;37:266\u2013271. https:\/\/doi.org\/10.1016\/s0168-8278(02)00162-9","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10085_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/liv.13001","volume":"36","author":"R Kumar","year":"2016","unstructured":"Kumar R, P\u00e9rez-Del-Pulgar S, Testoni B, Leboss\u00e9 F, Zoulim F. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA. Liver Int 2016;36(Suppl 1):72\u201377. https:\/\/doi.org\/10.1111\/liv.13001","journal-title":"Liver Int"},{"issue":"3","key":"10085_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0032-1323630","volume":"32","author":"B Roche","year":"2012","unstructured":"Roche B, Samuel D. Liver transplantation in delta virus infection. Semin Liver Dis 2012;32(3):245\u2013255. https:\/\/doi.org\/10.1055\/s-0032-1323630","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10085_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4254\/wjh.v7.i5.777","volume":"7","author":"Z Abbas","year":"2015","unstructured":"Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015;7(5):777\u2013786. https:\/\/doi.org\/10.4254\/wjh.v7.i5.777","journal-title":"World J Hepatol"},{"issue":"7","key":"10085_CR26","doi-asserted-by":"publisher","first-page":"a021576","DOI":"10.1101\/cshperspect.a021576","volume":"5","author":"M Rizzetto","year":"2015","unstructured":"Rizzetto M, Hepatitis D. Virus: introduction and epidemiology. Cold Spring Harb Perspect Med 2015;5(7):a021576. https:\/\/doi.org\/10.1101\/cshperspect.a021576","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"13","key":"10085_CR27","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1017\/S0950268818001942","volume":"146","author":"R Romeo","year":"2018","unstructured":"Romeo R, Petruzziello A, Pecheur EI, Facchetti F, Perbellini R, Galmozzi E, Khan NU, Di Capua L, Sabatino R, Botti G, Loquercio G. Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiol Infect 2018;146(13):1612\u20131618. https:\/\/doi.org\/10.1017\/S0950268818001942","journal-title":"Epidemiol Infect."},{"issue":"3","key":"10085_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4254\/wjh.v10.i3.352","volume":"10","author":"R Chauhan","year":"2018","unstructured":"Chauhan R, Lingala S, Gadiparthi C, Lahiri N, Mohanty SR, Wu J, Michalak TI, Satapathy SK. Reactivation of hepatitis B after liver transplantation: current knowledge, molecular mechanisms and implications in management. World J Hepatol 2018;10(3):352\u2013370. https:\/\/doi.org\/10.4254\/wjh.v10.i3.352","journal-title":"World J Hepatol"},{"issue":"11","key":"10085_CR29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/lt.21882","volume":"15","author":"S Saab","year":"2009","unstructured":"Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transplant 2009;15(11):1525\u20131534. https:\/\/doi.org\/10.1002\/lt.21882","journal-title":"Liver Transplant"},{"issue":"4","key":"10085_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jhep.2006.05.014","volume":"45","author":"DK Wong","year":"2006","unstructured":"Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol 2006;45(4):553\u2013559. https:\/\/doi.org\/10.1016\/j.jhep.2006.05.014","journal-title":"J Hepatol"},{"issue":"7","key":"10085_CR31","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1053\/j.gastro.2008.02.064","volume":"134","author":"LC Faria","year":"2008","unstructured":"Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, Fallot G, Ferrari TC, Guettier C, Dussaix E, Castaing D, Brechot C, Samuel D. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 2008;134(7):1890\u20132155. https:\/\/doi.org\/10.1053\/j.gastro.2008.02.064","journal-title":"Gastroenterology"},{"issue":"40","key":"10085_CR32","doi-asserted-by":"publisher","first-page":"14589","DOI":"10.3748\/wjg.v20.i40.14589","volume":"20","author":"CR Huang","year":"2014","unstructured":"Huang CR, Lo SJ. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus. World J Gastroenterol 2014;20(40):14589\u201314597. https:\/\/doi.org\/10.3748\/wjg.v20.i40.14589","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10085_CR33","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1128\/JVI.00430-14","volume":"88","author":"N Freitas","year":"2014","unstructured":"Freitas N, Cunha C, Menne S, Gudima SO. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J Virol 2014;88(10):5742\u20135754. https:\/\/doi.org\/10.1128\/JVI.00430-14","journal-title":"J Virol"},{"issue":"6","key":"10085_CR34","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.transproceed.2016.02.076","volume":"48","author":"A Baskiran","year":"2016","unstructured":"Baskiran A, Ozdemir F, Ince F, Barut B, Ersan V, Kutluturk K, Koc C, Isik B, Yilmaz S. Hepatitis B virus and hepatitis D virus recurrence in patients undergoing liver transplantation for hepatitis B virus and hepatitis B virus plus hepatitis D virus. Transplant Proc 2016;48(6):2119\u20132233. https:\/\/doi.org\/10.1016\/j.transproceed.2016.02.076","journal-title":"Transplant Proc"},{"key":"10085_CR35","doi-asserted-by":"publisher","first-page":"e920969","DOI":"10.12659\/AOT.920969","volume":"25","author":"G Brancaccio","year":"2020","unstructured":"Brancaccio G, Gaeta GB. Prophylaxis of hepatitis B virus (HBV) re-infection in liver transplantation: is the reappearance of hepatitis B surface antigen (HBsAg) significant? Ann Transplant 2020;25:e920969. https:\/\/doi.org\/10.12659\/AOT.920969","journal-title":"Ann Transplant."}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10085-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10085-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10085-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:25:46Z","timestamp":1630970746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10085-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10085"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10085-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, and Sezai Yilmaz declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Inonu University Institutional Review Board for Non-interventional Studies (Approval No: 2020\/760).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}